1. Home
  2. CPIX vs CRIS Comparison

CPIX vs CRIS Comparison

Compare CPIX & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPIX
  • CRIS
  • Stock Information
  • Founded
  • CPIX 1999
  • CRIS 2000
  • Country
  • CPIX United States
  • CRIS United States
  • Employees
  • CPIX N/A
  • CRIS N/A
  • Industry
  • CPIX Biotechnology: Pharmaceutical Preparations
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • CPIX Health Care
  • CRIS Health Care
  • Exchange
  • CPIX Nasdaq
  • CRIS Nasdaq
  • Market Cap
  • CPIX 68.7M
  • CRIS 32.8M
  • IPO Year
  • CPIX 2009
  • CRIS 2000
  • Fundamental
  • Price
  • CPIX $5.15
  • CRIS $3.22
  • Analyst Decision
  • CPIX
  • CRIS Strong Buy
  • Analyst Count
  • CPIX 0
  • CRIS 3
  • Target Price
  • CPIX N/A
  • CRIS $23.00
  • AVG Volume (30 Days)
  • CPIX 4.2M
  • CRIS 33.4K
  • Earning Date
  • CPIX 03-04-2025
  • CRIS 02-25-2025
  • Dividend Yield
  • CPIX N/A
  • CRIS N/A
  • EPS Growth
  • CPIX N/A
  • CRIS N/A
  • EPS
  • CPIX N/A
  • CRIS N/A
  • Revenue
  • CPIX $36,785,442.00
  • CRIS $10,259,000.00
  • Revenue This Year
  • CPIX N/A
  • CRIS N/A
  • Revenue Next Year
  • CPIX N/A
  • CRIS N/A
  • P/E Ratio
  • CPIX N/A
  • CRIS N/A
  • Revenue Growth
  • CPIX N/A
  • CRIS 0.44
  • 52 Week Low
  • CPIX $1.04
  • CRIS $2.86
  • 52 Week High
  • CPIX $6.43
  • CRIS $17.49
  • Technical
  • Relative Strength Index (RSI)
  • CPIX 68.22
  • CRIS 45.26
  • Support Level
  • CPIX $4.12
  • CRIS $3.05
  • Resistance Level
  • CPIX $5.29
  • CRIS $3.55
  • Average True Range (ATR)
  • CPIX 0.74
  • CRIS 0.19
  • MACD
  • CPIX 0.17
  • CRIS -0.01
  • Stochastic Oscillator
  • CPIX 70.57
  • CRIS 32.69

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: